PubRank

Y Ogiso

Author PubWeight™ 27.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cyclin G: a new mammalian cyclin with homology to fission yeast Cig1. Oncogene 1993 1.40
2 Gelsolin: a candidate for suppressor of human bladder cancer. Cancer Res 1995 1.33
3 Sex-determining gene(s) on distal 9p: clinical and molecular studies in six cases. J Clin Endocrinol Metab 2000 1.22
4 An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies. Cancer Gene Ther 2000 1.11
5 Effect of zinc ion on the hemolytic activity of thermostable direct hemolysin from Vibrio parahaemolyticus, streptolysin O, and Triton X-100. Infect Immun 1977 1.04
6 A specific protein, p92, detected in flat revertants derived from NIH/3T3 transformed by human activated c-Ha-ras oncogene. Exp Cell Res 1990 0.87
7 Expression of c-mos proto-oncogene in undifferentiated teratocarcinoma cells. Biochem Biophys Res Commun 1986 0.85
8 Pathological observations of natural cases of feline lymphosarcomatosis. Nihon Juigaku Zasshi 1974 0.84
9 Glucose-regulated stresses cause degradation of DNA topoisomerase IIalpha by inducing nuclear proteasome during G1 cell cycle arrest in cancer cells. J Cell Physiol 1999 0.84
10 Induction of teratocarcinoma cell differentiation. Effect of the inhibitors of DNA synthesis. Exp Cell Res 1983 0.84
11 A comprehensive system to explore p53 mutations. Am J Clin Pathol 1998 0.83
12 Resistance to oncogenic transformation in revertant R1 of human ras-transformed NIH 3T3 cells. Mol Cell Biol 1989 0.81
13 Pheochromocytomas and C-cell thyroid neoplasms in transgenic c-mos mice: a model for the human multiple endocrine neoplasia type 2 syndrome. Cancer Res 1992 0.81
14 Significance of the Grb2 and son of sevenless (Sos) proteins in human bladder cancer cell lines. IUBMB Life 2000 0.81
15 Suppression of pancreatic cancer by the dominant negative ras mutant, N116Y. J Surg Res 1996 0.81
16 [Clinical evaluation of RT-PCR method for detection of HCV-RNA: second report availability of RT-PCR system using PCR internal control for detection of HCV-RNA and the influence of interfering substances on the detection]. Rinsho Byori 1998 0.80
17 Pheochromocytoma arising from an accessory adrenal gland in a patient with multiple endocrine neoplasia type 2A: transient development of clinical manifestations after hemorrhagic necrosis. Endocr J 1998 0.80
18 Suppressive effects of dominant negative ras mutant N116Y on transformed phenotypes of human bladder cancer cells. Cancer Lett 2000 0.80
19 Suppression of Erk activation and in vivo growth in esophageal cancer cells by the dominant negative Ras mutant, N116Y. Int J Cancer 1998 0.80
20 Enhanced expression of ras gene products in psoriatic epidermis. Arch Dermatol Res 1988 0.79
21 Reversible and irreversible stages in the transition of cell surface marker during the differentiation of pluripotent teratocarcinoma cell induced with retinoic acid. Exp Cell Res 1982 0.79
22 The significance of Ras guanine nucleotide exchange factor, son of sevenless protein, in renal cell carcinoma cell lines. J Urol 1997 0.79
23 Epidermal growth factor receptor mRNA is not increased in psoriatic skin. J Dermatol 1990 0.78
24 Hepatocyte growth factor and c-met expression in Long-Evans Cinnamon rats with spontaneous hepatitis and hepatoma. Hepatology 1996 0.78
25 Psychotic symptoms in depression and borderline personality disorder. J Affect Disord 1993 0.78
26 Induction of apoptosis by a dominant negative H-RAS mutant (116Y) in K562 cells. Exp Cell Res 1994 0.78
27 Differential Na+,K(+)-ATPase activity and cisplatin sensitivity between transformants induced by H-ras and those induced by K-ras. Int J Cancer 1994 0.78
28 Mechanism of O2- (-) and H2O2-induced stimulation of sugar transport in mouse fibroblast BALB/3T3 cells. Biochim Biophys Acta 1988 0.78
29 Involvement of Ras in the expression of glycolipid sulfotransferase in human renal cancer cells. Int J Cancer 1997 0.77
30 c-myc expression and transformed phenotypes in hybrid clones between mouse plasmacytoma S194 cells and normal spleen cells or fibroblasts. Int J Cancer 1988 0.77
31 Germline mutations of the APC gene in two Japanese adenomatous polyposis patients. Jpn J Hum Genet 1997 0.76
32 Successful cessation of transmitting healthcare -- associated infections due to Burkholderia cepacia complex in a neonatal intensive care unit in a Japanese children's hospital. Eur J Med Res 2011 0.75
33 Aminoacyl transfer RNA formation. Binding of cations to transfer RNA and its role in aminoacyl transfer RNA formation. J Biochem 1976 0.75
34 Protective effects of macrophage-derived interferon against encephalomyocarditis virus-induced diabetes mellitus in mice. Lab Anim Sci 1995 0.75
35 Elevated gelsolin and alpha-actin expression in a flat revertant R1 of Ha-ras oncogene-transformed NIH/3T3 cells. Biochem Biophys Res Commun 1990 0.75
36 Circumvention of Cisplatin resistance in h-ras transformed-nih/3t3 cells by suppressor mutant of h-ras. Int J Oncol 1992 0.75
37 [Treatment of borderline personality disorder--with special reference to the psychotherapy]. Seishin Shinkeigaku Zasshi 1990 0.75
38 Unresponsiveness of both non-rearranged and rearranged c-myc to serum stimulation in a mouse plasmacytoma S194. Leuk Res 1987 0.75
39 Aminoacyl transfer RNA formation. VII. Lack of correlation between aminoacylation and PPi-ATP exchange catalyzed by isoleucyl-tRNA synthetase of Escherichia coli in the presence of various divalent cations. J Biochem 1976 0.75
40 Effects of beta-mercaptoethanol-containing medium and feeder cells on the differentiation of embryonal carcinoma cells. Differentiation 1982 0.75
41 Reconfirmation of replacement of magnesium ion requirement by polyamines in isoleucyl-tRNA formation in Escherichia coli. FEBS Lett 1976 0.75
42 Possible involvement of a Na+/H+ antiporter in the stimulation of hexose transport in Swiss 3T3 cells by a phorbol ester and growth factors. Cell Struct Funct 1987 0.75
43 Dome formation induced by v-H-ras oncogene in a human choriocarcinoma cell line. Placenta 1996 0.75
44 [Clinical evaluation of RT-PCR method for detection of HCV-RNA--with special reference to Amplicor HCV]. Rinsho Byori 1997 0.75
45 Chronic meningoencephalitis due to cytomegalovirus infection in a nonimmunocompromised patient: an autopsy case. J Child Neurol 1998 0.75
46 Reduced induction of c-fos but not of c-myc expressions in a nontumorigenic revertant R1 of Ej-ras-transformed NIH/3T3 cells treated with 12-O-tetradecanoylphorbol-13-acetate (TPA). Exp Cell Res 1989 0.75
47 [Gastric ulcer in pigs as an animal model of human disease (author's transl)]. Jikken Dobutsu 1979 0.75
48 Mode of cell surface marker changes during retinoic acid-induced differentiation in pluripotent embryonal carcinoma cells. Exp Cell Res 1983 0.75
49 [A case of simple coarctation]. Kyobu Geka 1999 0.75
50 Inhibition by pertussis toxin of fibroblast growth factor-stimulated hexose transport in Swiss 3T3 cells. Biochim Biophys Acta 1987 0.75
51 [A case positive for the inhibitor for coagulation factor V]. Rinsho Byori 1999 0.75
52 Object images of eating disorder patients. Jpn J Psychiatry Neurol 1993 0.75
53 Reduced DNase I sensitivity of the rearranged c-myc gene in somatic cell hybrids between murine plasmacytoma cells and fibroblasts. Exp Cell Res 1989 0.75
54 Suppression of transformed phenotypes and c-myc expression in a mouse plasmacytoma line after cell fusion with normal fibroblasts. IARC Sci Publ 1988 0.75
55 [A case of hookworm infestation with dissociation values between FDP-E and FDP-D dimer]. Rinsho Byori 2001 0.75